an approach known as CAR-T cell therapy. However, a major drawback of this strategy is the lack of longevity following infusion. The immunosuppressive nature of the tumor microenvironment (TME) exerts ...
The research also showed that using TME with existing investigative methods offers critical new insights into Parkinson's disease by revealing how the proteins behave in living blood cells—a ...
In addition, this bispecific antibody activates immune cells within the tumor microenvironment (TME). This new therapeutic strategy has been evaluated in patient-derived models of HER2+ ...